T he conventional pacing systems consist of a small size-battery, an electronic circuit and leads. Despite improvements in diagnostic and therapeutic features, transvenous leads remain the weakest link of the pacing system. Nowadays, two types of leadless cardiac pacemaker (LCP) exist leading stimulation from the right ventricle (RV) apex or low septum at the desired lower rate, with rate responsive algorithms. We report our experience with an LCP implant in a severely obese patient and demonstrate the feasibility of the procedure and the excellent telemetric (conductive) communication between the LCP and the programmer despite the critical mass of the patient.
The delivery system (Nanostim™ Delivery System Catheter) with the LCP mounted on a deflectable tip was advanced under fluoroscopic guidance through the inferior vena cava to the right atrium and then RV. The pacemaker was successfully implanted in the RV low septum, screwing it with 1.25 turns. The tug test for stability was performed ( Figure 3A 
Discussion
Since the first idea to use 'electricity' for heart stimulation in 1774 and the first complete implant of a pacing system in 1959, 1 the technology of cardiac devices has evolved considerably to treat bradyarrhythmia and tachyarrhythmias. Nowadays, the conventional pacing systems consist of a small size-battery, an electronic circuit and leads. Despite improvements in diagnostic and therapeutic features, transvenous leads remain the weakest link of the pacing system. There are 65,000 lead failures annually in more than 4 million implanted systems worldwide Implant success rate was 97% and all parameters were comparable to standard pacemakers. The 1-year follow-up reported stable pacing parameters with no infections, dislodgments or other complications.
Despite the current guidelines for the positioning of the LCP, indications may also be extended for borderline cases, after a collegial medical decision regarding the best strategy for each patient. Recently, Tjong et al. 6 reported their successful leadless implant experience in a patient with a previous bilateral lead extraction for infected system and Fundim et al. 7 reported their successful experience of transcatheter LCP implantation for complete heart block following transcatheter aortic valve replacement.
To our knowledge this is the first reported case of a leadless pacemaker implant in a severely obese patient. We demonstrate the feasibility of 
